13F
中

MLTX MOONLAKE IMMUNOTHERAPEUTICS

2026Q1 · CUSIP 61559X104 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
146
Δ holders QoQ
+15
Breadth percentile
Top 21%
Whale holders
71
Δ whales
+7
Inst. holding value
$1.2B
New positions
40
Closed positions
25
Price momentum (1Q)
-6.2%
Put / Call
4/8

Breadth history (34 quarters)

2022Q2: Δ+23 · h=24 2022Q3: Δ+0 · h=24 2022Q4: Δ+10 · h=34 2023Q1: Δ+10 · h=44 2023Q2: Δ+42 · h=86 2023Q3: Δ+34 · h=120 2023Q4: Δ+7 · h=127 2024Q1: Δ-12 · h=115 2024Q2: Δ-3 · h=112 2024Q3: Δ-2 · h=110 2024Q4: Δ+7 · h=117 2025Q1: Δ+19 · h=136 2025Q2: Δ-6 · h=130 2025Q3: Δ+5 · h=135 2025Q4: Δ-4 · h=131 2026Q1: Δ+15 · h=146 2022Q2: holders=24 2022Q3: holders=24 2022Q4: holders=34 2023Q1: holders=44 2023Q2: holders=86 2023Q3: holders=120 2023Q4: holders=127 2024Q1: holders=115 2024Q2: holders=112 2024Q3: holders=110 2024Q4: holders=117 2025Q1: holders=136 2025Q2: holders=130 2025Q3: holders=135 2025Q4: holders=131 2026Q1: holders=146 -42 -21 +0 +21 +42 2188154 22Q222Q423Q223Q424Q224Q425Q225Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 4 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q1 Top 12% +34.3% -66.9%
2023Q3 Top 3% +37.0% -4.1%
2023Q2 Top 3% -34.9% +4.6%
2023Q1 Top 16% +99.6% +39.4%

Options Sentiment

Put holders
4
QoQ: -3
Call holders
8
QoQ: -1

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-3.88
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2022-06-30: EPS -0.34 2022-09-30: EPS -0.27 2023-03-31: EPS -0.23 2023-06-30: EPS -0.23 2023-09-30: EPS -0.18 2023-12-31: EPS -0.09 2024-03-31: EPS -0.22 2024-06-30: EPS -0.39 2024-09-30: EPS -0.56 2024-12-31: EPS -0.72 2025-03-31: EPS -0.63 2025-06-30: EPS -0.87 2025-09-30: EPS -1.10 2025-12-31: EPS -0.93 2026-03-31: EPS -0.98 -1.21 -0.61 0.00 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)